1. Introduction {#sec1}
===============

In the Americas, an average of 6.2 snakebites per 100,000 population (about 57,500 accidents) is estimated to occur annually, leading to a fatality rate of 0.04 per 100,000 population ([@bib16]). The genus *Bothrops* (lanceheads), distributed from Mexico to southern Argentina, is responsible for the majority of envenomings in Latin America ([@bib16]). Classified within the Viperidae family, this genus includes 45 species listed in the Reptile Database (<http://www.reptile-database.org>) and has been the subject of dynamic taxonomic reclassifications within the bothropoid lineages in the last two decades ([@bib88], [@bib25], [@bib13], [@bib14], [@bib3]). Despite the medical relevance of species within the *Bothrops* complex (*sensu lato*), knowledge on the characteristics of their venoms is still limited, or unavailable, for some species.

The growing body of information on the composition of viperid venoms, as provided by "omics" approaches, has revealed the existence of a limited number of protein families that are generally shared among conspecific species, with both qualitative and quantitative variations ([@bib10], [@bib11], [@bib50], [@bib29], [@bib80], [@bib85], [@bib75]). Knowledge of this variability is essential for the production of broad-coverage therapeutic antivenoms to confront snakebite envenomings. Also, the study of inter- and intraspecific venom variability may shed light on understanding the evolutionary pathways that have shaped the present-day landscape of the snake venom toxin arsenals.

Perú harbors a rich herpetofauna, which includes 34 species or subspecies of venomous snakes distributed in two families, Elapidae and Viperidae. Sixteen coral snakes represent the former, all included in the genus *Micrurus* of subfamily Elapinae, and a single species of sea snake, *Hydrophis platurus* within subfamily Hydrophiinae. Viperidae includes 17 pitviper species ([@bib15]) within the genera *Bothrops*, *Bothriechis*, *Bothrocophias*, *Porthidium*, *Crotalus*, and *Lachesis* (taxonomical nomenclature in the present work follows the proposal of [@bib14] for the *Bothrops* complex, *sensu lato*). Viperidae species are responsible for the vast majority of the estimated 1500--2500 snakebites/year recorded in Perú ([@bib57]), resulting in a mortality rate of not less than 0.043/100,000 population ([@bib16]).

Previous studies have examined various biochemical aspects and toxic activities of the venoms of Viperidae snakes inhabiting Perú ([@bib72], [@bib60], [@bib37], [@bib41], [@bib31], [@bib67]), and their neutralization ([@bib42], [@bib68], [@bib28], [@bib24]). However, information on most venoms of these species is still partial, and more efforts are needed to gain a broader knowledge of their general properties. In the present study, we have comparatively explored the chromatographic and electrophoretic profiles of the venoms of twelve species of pitvipers, as well as their proteolytic and phospholipase A~2~ (PLA~2~) activities. Besides, proteomic profiles were analyzed for nine of the venoms using a shotgun approach. These comparative analyses revealed important differences in the expression of PLA~2~s among the species, which relate to variations in toxicological activities attributed to these enzymes and their related PLA~2~-like homologs.

2. Materials and methods {#sec2}
========================

2.1. Venoms {#sec2.1}
-----------

Venom pools were obtained from adult specimens collected in Perú, from the species and locations indicated in [Table 1](#tbl1){ref-type="table"}. In some comparative experiments, venoms of species from other regions of Latin America were included: *Bothrops alternatus* (Coronel Pringles, Argentina), *B. neuwiedii* (Tacuarembó, Uruguay), *B. asper* (Pacific versant, Costa Rica), and *Bothriechis schlegelii* (Costa Rica).Table 1Venoms from Viperidae species of Perú analyzed in the present study, and their localities.Table 1**Species**[a](#tbl1fna){ref-type="table-fn"}**Common namen**[b](#tbl1fnb){ref-type="table-fn"}**DistrictProvinceDepartment***Bothrops atrox*jergón de la selva60Llata, Chaglia, Puerto Inca, Codo del PozuzoHumalíes, Pachitea, Puerto IncaHuánuco*Bothrops barnetti*macanche20Quebrada Honda, OlmosTalara, LambayequePiura, Lambayeque*Bothrops bilineatus*loro machaco10Pichanaki, Vitoc, ChanchamayoChanchamayoJunin*Bothrops taeniata (castelnaudi)*jergón de árbolndSatipoJaujaJunin*Bothrops chloromelas*--8HuancabambaHuancabambaPiura*Bothrops oligolepis (peruvianus)*jergón negro8SatipoJaujaJunin*Bothrops pictus*jergón de la costa5PachacamacLimaLima*Bothrocophias andianus*jergona4Macchu PicchuUrubambaCusco*Bothrocophias hyoprora*jergón shushupe10Puerto Pakuy, ImazaBaguaAmazonas*Bothrocophias microphtalmus*jergón pudridorandPichanakiChanchamayoJunin*Bothriechis schlegelii*loro4Reserva de TumbesZarumillaTumbes*Lachesis muta*shushupe10Alto Marañón, Nazareth, PijuayalBagua, CondorcanquiAmazonas[^1][^2]

2.2. SDS-PAGE {#sec2.2}
-------------

Venom proteins were separated by SDS-PAGE using pre-cast gradient gels (4--20%; Bio-Rad), either unreduced or after reduction with 2-mercaptoethanol (5 min at 95 °C). Samples (30 μg) were separated at 150 V, along with molecular weight standards (Bio-Rad). Proteins were visualized by Coomassie blue R-250 staining and electrophoretic patterns were recorded with the ImageLab™ software (Bio-Rad).

2.3. Reverse phase-HPLC profiling {#sec2.3}
---------------------------------

Chromatographic profiles of venoms were obtained by RP-HPLC using a C~18~ column (250 × 4.6 mm, 5 μm particle diameter; Phenomenex) in a model 1220 instrument (Agilent) monitored at 215 nm. Venoms (1.5--2.0 mg) were dissolved in purified water (18 MΩ/cm) containing 0.1% trifluoroacetic acid (TFA; solution A), injected, and eluted with a gradient toward acetonitrile with 0.1% TFA (solution B), at a flow rate of 1 mL/min, for a total time of 94 min: 0% B for 5 min, 0--15% B in 10 min, 15--45% B in 60 min, 45--70% B in 10 min, and 70% B for 9 min ([@bib45]).

2.4. Phospholipase A~2~ activity {#sec2.4}
--------------------------------

Phospholipase A~2~ (PLA~2~) activity of the venoms was assayed using the synthetic substrate 4-nitro-3-octanoyloxy-benzoic acid (NOBA), as described ([@bib58]). Various amounts of venoms (5, 10, or 20 μg), in 25 μL, were added to 25 μL of NOBA (1 mg/mL acetonitrile) and 200 μL of 10 mM Tris, 10 mM CaCl~2~, 0.1 M NaCl (pH 8.0), in 96-well microplates. Blanks in which venom was replaced with buffer were included. The mixtures were incubated at 37 °C for 60 min, and final absorbances at 450 nm were measured in a microplate reader (Multiskan FC, Thermo), using three replicates for each venom concentration.

2.5. Proteolytic activity {#sec2.5}
-------------------------

Proteolytic activity of the venoms was determined using azocasein (10 mg/mL in 50 mM Tris-HCl, 0.15 M NaCl, 5 mM CaCl~2~, pH 8.0) as substrate, as previously described ([@bib38]). Various amounts of venoms (5, 10, or 20 μg) were incubated with azocasein at 37 °C for 90 min, in a total volume of 100 μL, and the reaction was stopped by adding 200 μL of 5% trichloroacetic acid (TCA). Blanks in which venom was omitted were included. After centrifugation of the microplates, 150 μL of the supernatant was transferred to clean wells, and 150 μL of 0.5 M NaOH was added for color development. Absorbances were measured at 450 nm in a microplate reader (Multiskan FC, Thermo), using three replicates for each venom concentration.

2.6. Proteomic profiling {#sec2.6}
------------------------

Venoms from nine species were analyzed by a bottom-up shotgun proteomic approach. Samples of 15 μg were reduced with 10 mM dithiothreitol for 30 min at 56 °C, alkylated with 50 mM iodoacetamide for 20 min in the dark, and digested with sequencing grade trypsin at 37 °C overnight, in a total volume of 40 μL. After the addition of 0.5 μL of formic acid, the resulting tryptic peptide mixtures were centrifuged and separated by RP-HPLC on a nano-Easy 1200 chromatograph (Thermo) on-line with a Q-Exactive Plus® mass spectrometer (Thermo). Twelve μL of peptide mixture, containing 0.7 μg, were loaded on a C~18~ trap column (75 μm × 2 cm, 3 μm particle; PepMap, Thermo), washed with 0.1% formic acid (solution A), and separated at 200 nL/min on a C~18~ Easyspray® column (75 μm × 15 cm, 3 μm particle; PepMap, Thermo). A gradient toward solution B (80% acetonitrile, 0.1% formic acid) was developed in a total of 120 min (1--5% B in 1 min, 5--26% B in 84 min, 26--80% B in 30min, 80--99% B in 1 min, and 99% B in 4 min). MS spectra were acquired in positive mode at 2.0 kV, with a capillary temperature of 200 °C, using 1 μscan in the range 400--1600 m/z, maximum injection time of 50 msec, AGC target of 1 × 10^6^, and resolution of 70,000. The top 10 ions with 2--5 positive charges were fragmented with AGC target of 3 × 10^6^, minimum AGC 2 × 10^3^, maximum injection time 110 msec, dynamic exclusion time 5 s, and resolution 17,500. MS/MS spectra were processed against protein sequences contained in the UniProt/SwissProt database (Serpentes, October 2019) using Peaks X® (Bioinformatics Solutions) and matches were assigned to known protein families by similarity. Cysteine carbamidomethylation was set as a fixed modification, while deamidation of asparagine or glutamine and methionine oxidation were set as variable modifications, allowing up to 3 missed cleavages by trypsin. Parameters for match acceptance were set to FDR\<0.1%, detection of at least one unique peptide, and −10lgP protein score ≥100.

2.7. Myotoxicity assay {#sec2.7}
----------------------

The myotoxic effect of the venoms of *Bothrops barnetti* and *Bothrocophias andianus* (selected as examples of venoms nearly devoid of PLA~2~s) was tested in mice. The venom of *B. asper* from the Pacific versant of Costa Rica, known to be abundant in PLA~2~s ([@bib2]), was included in this assay as a positive control. Groups of five CD-1 mice (18--20 g body weight) received an intramuscular venom injection (50 μg/50 μL) in the gastrocnemius. After 3 h, blood was obtained from the tip of the tail into heparinized capillary tubes, centrifuged, and plasma (4 μL) was assayed for creatine kinase (CK) activity using a kinetic commercial kit (CK-Nac, Biocon Diagnostik). A control group of mice received a similar injection of phosphate-buffered saline (PBS; pH 7.2) instead of venom. This experiment followed the ethical guidelines of the Institutional Committee for the Use and Care of Animals (CICUA) of the University of Costa Rica (No. 021--17). Statistical significance of the differences between groups was determined by ANOVA, followed by Tukey-Kramer post-hoc test, using the InStat v.3 (GraphPad) software.

3. Results {#sec3}
==========

3.1. Electrophoresis {#sec3.1}
--------------------

Venom SDS-PAGE patterns, under non-reducing and reducing conditions, are shown in [Fig. 1](#fig1){ref-type="fig"}. Although none of the inter-species patterns are entirely identical, significant resemblances are evident between several venoms, for example, *Bothrops atrox*, *B. barnetti*, *B. pictus*, and *B. neuwiedii*, especially after disulfide bond reduction. More differences appear in the unreduced electrophoretic patterns than in reduced ones, suggesting inter-species variations in the oligomeric association of subunits of similar molecular mass. Notably, the electrophoretic pattern of *Bothriechis schlegelii* venom from Perú appears indistinguishable from that of the same species originating from Costa Rica, under both conditions ([Fig. 1](#fig1){ref-type="fig"}). All major venom proteins distributed below \~100 kDa. The most prominent reduced protein bands migrated at \~50, \~23, and \~15 kDa.Fig. 1SDS-PAGE profiles of venoms from twelve viperid species of Perú, unreduced (A, B) or reduced (C, D). Venoms of some species from other locations are included: *Bothrops asper* from the Pacific (P) or Caribbean (C) regions of Costa Rica, *B. alternatus* from Argentina, *B. neuwiedi* from Uruguay, and *B. schlegelii* from Costa Rica (CR). An additional sample of *B. atrox* venom from Perú is indicated with an asterisk. Molecular weight (Mw) markers are indicated in kDa. Proteins were stained with Coomassie brilliant blue G-250. The venom of *B. oligolepis* could not be analyzed in this technique due to insufficient amount. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

3.2. RP-HPLC profiles {#sec3.2}
---------------------

Venoms were analyzed using a previously standardized C~18~ RP-HPLC separation protocol ([@bib45]). Its application in several proteomic studies on snake venoms has shown that monomeric PLA~2~s and PLA~2~-like homologs elute within the range indicated with a shadowed dotted box in [Fig. 2](#fig2){ref-type="fig"}. Venoms varied largely regarding the presence of chromatographic peaks within this region, and can be separated into two types, namely those presenting conspicuous peaks (blue frame in [Fig. 2](#fig2){ref-type="fig"}) and those having barely detectable peaks. The venoms of *Bothriechis schlegelii* and *Bothrocophias hyoprora* showed the most intense peaks in this region, comparable to those of *Bothrops asper* venom from Costa Rica, used as a reference for the elution of PLA~2~s ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2C~18~ reverse-phase HPLC profiles of venoms from twelve viperid species of Perú. The venom of *Bothrops asper* from Costa Rica was included as a reference. The dotted light green shaded area indicates the known elution region for PLA~2~/PLA~2~-like proteins in viperid venoms in this standardized chromatographic gradient. Venoms were divided into two groups, those with evident peaks in such region (enclosed within the blue frame) and those with very minor peaks. For reference to colors, the reader is referred to the web version of this article. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

Since electrophoretic analysis showed a very high similarity of *Bothriechis schlegelii* venoms collected in Perú and Costa Rica ([Fig. 1](#fig1){ref-type="fig"}), their RP-HPLC profiles were determined and compared in [Fig. 3](#fig3){ref-type="fig"}. As shown, the two profiles are virtually superimposable, confirming their remarkable high similarity.Fig. 3Superposition of the C~18~ reverse-phase HPLC profiles of the venoms of *Bothriechis schlegelii* from Costa Rica (CR; green trace) and Perú (blue trace). For reference to colors, the reader is referred to the web version of this article. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

3.3. Phospholipase A~2~ and proteolytic activities {#sec3.3}
--------------------------------------------------

PLA~2~ activity of the venoms on the NOBA substrate was highly variable, as presented in [Fig. 4](#fig4){ref-type="fig"}. This activity was strikingly low in the case of *Bothrops oligolepis*, *B. barnetti*, *Bothrocophias andianus*, *Bothrocophias hyoprora*, and *Lachesis muta* venoms. In contrast, *Bothrops atrox*, *B. pictus*, *B. taeniata*, and *Bothriechis schlegelii* venoms were highly active in this assay, while low to intermediate activities were recorded for *Bothrops chloromelas*, *B. bilineatus*, and *Bothrocophias microphtalmus* venoms.Fig. 4Phospholipase A~2~ activity of venoms from twelve viperid species of Perú on 4-nitro-3-octanoyloxy-benzoic acid. The venom of *Bothrops asper* from Costa Rica was included as a reference. Each point represents the mean ± SD of three replicates.Fig. 4

On the other hand, proteolytic activity on the azocasein substrate was more similar among the different venoms ([Fig. 5](#fig5){ref-type="fig"}), but *Bothriechis schlegelii*, *Bothrops taeniata*, and *Lachesis muta* venoms showed a slightly lower proteolytic activity than the rest.Fig. 5Proteolytic activity of venoms from twelve viperid species of Perú on azocasein. The venom of *Bothrops asper* from Costa Rica was included as a reference. Each point represents the mean ± SD of three replicates.Fig. 5

3.4. Myotoxicity {#sec3.4}
----------------

The venoms of *Bothrops barnetti* and *Bothrocophias andianus* were selected as examples of venoms virtually devoid of PLA~2~s in the RP-HPLC profiles, to test whether this phenotypic trait would correlate with toxic activities that are known to depend mainly on these proteins, such as *in vivo* myotoxicity. As shown in [Fig. 6](#fig6){ref-type="fig"}, intramuscular injection of these two venoms in mice did not induce a significant increment of plasma CK activity, in contrast to a venom (*Bothrops asper*, used as a reference) known to contain abundant PLA~2~ (Asp49) and PLA~2~-like (Lys49) myotoxins.Fig. 6Comparative evaluation of the myotoxic activity of the venoms of **(A)***Bothrops barnetti* and **(B)***Bothrocophias andianus* (Perú), compared to *Bothrops asper* (Costa Rica) in mice. Venoms were injected by the intramuscular route into groups of five mice. A control group received an injection of vehicle (PBS) alone. After 3 h the plasma creatine kinase (CK) activity was determined. Each bar represents the mean ± SD (n = 5). No statistical difference (p \> 0.05) was observed between CK levels of PBS and *B. barnetti* venom, or PBS and *B. andianus* venom. *B. asper* venom was significantly different from both groups, in both independent experiments.Fig. 6

3.5. Shotgun proteomic profiling {#sec3.5}
--------------------------------

Nine of the twelve venoms here studied were subjected to a bottom-up shotgun proteomic profiling. The complete dataset of matches with known proteins in the Uniprot "Serpentes" database is presented in [Supplemental Table S1](#appsec1){ref-type="sec"}, and the different protein families identified in each venom are summarized in [Table 2](#tbl2){ref-type="table"}. Venom protein families detected by this qualitative approach ranged from 9 (*Bothrops barnetti*) to 13 (*B. atrox*, *B. oligolepis*, *B. chloromelas*). The most variable protein family detected corresponded to hyaluronidase (HYA), found in three out nine venoms, and vascular endothelial growth factor (VEGF), found in five out of nine ([Table 2](#tbl2){ref-type="table"}). Nerve growth factor (NGF) was present in seven venoms, while phospholipase B (PLB) phosphodiesterase (PDE) and cysteine-rich secretory proteins (CRISP) were found in eight. Other major protein families commonly found in viperid venoms were detected in all nine species.Table 2Protein families identified in nine venoms from Viperidae species of Perú by bottom-up shotgun proteomics.Table 2**Snake speciesMP**\***SPPLA**~**2**~**LAAOCTLNUCGCYCRiSPPDEPLBNGFVEGFHYATotal N°***Bothrops atrox***✓✓✓✓✓✓✓✓✓✓✓✓✓**13*Bothrops oligolepis***✓✓✓✓✓✓✓✓✓✓✓✓✓**13*Bothrops chloromelas***✓✓✓✓✓✓✓✓✓✓✓✓✓**13*Bothrocophias andianus***✓✓✓✓✓✓✓✓✓✓✓✓**(−)12*Bothrops pictus***✓✓✓✓✓✓✓**(−)**✓✓✓✓**(−)11*Bothrocophias microphtalmus***✓✓✓✓✓✓✓✓✓✓✓**(−)(−)11*Bothrocophias hyoprora***✓✓✓✓✓✓✓✓✓**(−)**✓**(−)(−)10*Bothrops bilineatus***✓✓✓✓✓✓✓✓✓✓**(−)(−)(−)10*Bothrops barnetti***✓✓✓✓✓✓✓✓**(−)**✓**(−)(−)(−)9Family presence100%100%100%100%100%100%100%89%89%89%77%56%33%[^3][^4]

3.6. Relationship of the phospholipase A~2~ low/high phenotypes to phylogeny {#sec3.6}
----------------------------------------------------------------------------

Differences in the expression of PLA~2~s in viperids of the bothropoid lineage were mapped onto the partial phylogeny described by [@bib14] in [Fig. 7](#fig7){ref-type="fig"}, using results of the present study together with data from the literature (evaluated either by proteomic analyses or by reported isolation of PLA~2~s). The obtained cladogram shows that the majority of bothropoid venoms studied to date typically present PLA~2~s (indicated with pink dots). One notable exception is *Bothrops cotiara* from Brazil, reported lacking these enzymes ([@bib83]). However, *B. cotiara* has also been reported to have PLA~2~s as the most abundant venom components in the case of specimens collected in Argentina ([@bib20]), and was therefore indicated with both pink and blue symbols in [Fig. 7](#fig7){ref-type="fig"}.Fig. 7Partial phylogenies of bothropoid viperids showing the relationships of species reported to produce venoms with high (pink dots) and low (blue dots) phospholipase A~2~ contents. The species from Perú analyzed in the present study are indicated by names in corresponding pink or blue colors. The phylogenetic trees were generated by [@bib14] using a total evidence approach from morphological, ecological, and mtDNA sequences (12 S and 16 S rRNA). Phylogenetic reconstruction included **(A)** or excluded **(B)** sequences from ND4 and cytb genes. For reference to colors, the reader is referred to the web version of this article. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 7

In addition to *B. cotiara* from Brazil, another bothropoid species with barely detectable amounts of venom PLA~2~s (0.7%) is *Bothrops ayerbei* ([Supplemental Fig. S1](#appsec1){ref-type="sec"}; [@bib59]), a lineage of the *B. asper* species complex ([@bib77]).

In contrast to the widespread presence of PLA~2~s in characterized venoms of most species included in the genus *Bothrops* (*sensu lato*) ([Fig. 7](#fig7){ref-type="fig"}), the chromatographic profiles of six out of the twelve venoms of species from Perú here studied revealed a phenotype in which PLA~2~s are notably scarce: *Bothrops barnetti*, at the base of the "alternatus" clade ([@bib14]), *Bothrocophias andianus* and *B. microphtalmus*, clustered in the "microphtalmus" clade, and *Bothrops chloromelas*, *B. bilineatus*, and *B. oligolepis*, in the "taeniata" clade ([Fig. 7](#fig7){ref-type="fig"}). The venom of *Bothrocophias hyoprora* differed sharply in this regard from those of other *Bothrocophias* species (*B. andianus* and *B. microphtalmus*), showing a major protein peak in the PLA~2~-eluting region, and rather resembling the venom of *Bothrocophias campbelli* ([Supplemental Fig. S1](#appsec1){ref-type="sec"}; [@bib69]), a species not represented in the phylogenetic trees displayed in [Fig. 7](#fig7){ref-type="fig"}.

4. Discussion {#sec4}
=============

Compositional, biochemical, and toxicological characteristics of the venoms of several species of the *Bothrops* complex (*sensu lato*) remain unexplored. In this study, the venoms of twelve viperid species that inhabit Perú were analyzed using electrophoretic, chromatographic, and enzymatic profiling for PLA~2~ and proteolytic activities *in vitro*. Also, their proteomic qualitative profiles were determined using a shotgun approach. Results provide additional information to previous studies on biochemical and toxicological aspects of snake venoms from this South American country ([@bib72], [@bib60], [@bib37], [@bib41], [@bib31]).

In general, venom SDS-PAGE profiles did not deviate from the typical patterns observed in viperids by this technique but revealed some resemblances and moderate differences among the species. Remarkably, the venom of *B. schlegelii* from Perú showed identical electrophoretic and chromatographic profiles to that of the same species found in Costa Rica, separated by a distance of more than 2000 km. This was unexpected, considering that a previous comparison of *B. schlegelii* venoms from Costa Rica and Colombia reported significant intra-specific differences in electrophoretic and toxicological parameters ([@bib65]). Also, there are marked differences in external characters, mainly scutellation and color patterns, between the Central American populations and those at the southern extreme of the distribution of this species in Ecuador and Perú ([@bib12]). Moreover, venoms of *Bothriechis* are known for their extremely high inter-species variability ([@bib26], [@bib48], [@bib49], [@bib50], [@bib11], [@bib64]).

Comparison of venom RP-HPLC profiles revealed an unexpected feature since six out of the twelve species studied presented only minor protein peaks in the elution region known to correspond to PLA~2~s as observed in several proteomic studies based on this chromatographic protocol (reviewed by [@bib50], [@bib45]). This particular characteristic had been observed in venoms from only a few of the bothropoid species studied until now, such as *B. ayerbei* from Colombia ([@bib59]), and *B. cotiara* from Brazil ([@bib83]). Most commonly, venoms of species within the *Bothrops* complex display prominent to medium-intensity peaks in the PLA~2~/PLA~2~-like eluting region. In contrast, venoms from six species of Perú here studied presented a low-PLA~2~ phenotypic feature. These observations point to an apparent dichotomy among bothropoid venoms, regarding the occurrence of high to scarce levels of PLA~2~ expression, and may bear practical relevance in selecting species whose venoms are used for antivenom production.

Venom compositional dichotomies are not infrequent in other taxonomic groups of venomous snakes. For example, rattlesnakes (*Crotalus* species) display either type I or type II venoms, defined as containing inverse proportions of metalloproteinases and PLA~2~s, respectively ([@bib52], [@bib53]). Another example relates to venoms of New World coral snakes (*Micrurus* species), which express either 'PLA~2~-rich' or '3FTx (three-finger toxin)-rich' phenotypes ([@bib27], [@bib51], [@bib74]). In contrast to the streamlined 3FTx neurotoxic venoms of non-spitting, particularly African, cobras (*Naja haje*, *N. nivea*, *N. annulifera*) ([@bib54]; Silva [@bib20], [@bib81]; unpublished results), variable expression of PLA~2~s has also been observed in cytotoxic venom proteomes among species of African (*N. nubiae*, *N. pallida*, *N. nigricollis*, *N. mossambica*) ([@bib63]) and Asian (*N. sumatrana*, *N. siamensis*, *N. philippinensis*) ([@bib17], [@bib81], [@bib82]) spitting cobras. The emergence of venom spitting in cobras is tightly linked with convergent upregulation of PLA~2~ toxins, which potentiate the nociceptive action of their venoms compared to those of their non-spitting counterparts ([@bib40]). Enhanced pain caused by spitting cobras is explicitly associated with the defensive use of venom, rather than for prey subjugation ([@bib40]).

The variable expression of PLA~2~/PLA~2~-like proteins in the Peruvian *Bothrops* venoms here studied showed only partial correlation with a functional assay for enzymatic hydrolysis of the NOBA substrate. This result is expected, since protein peaks in the known PLA~2~-eluting RP-HPLC region may correspond to either Asp49 PLA~2~ enzymes (catalytically active) or enzymatically inactive (but highly myotoxic) Lys49 PLA~2~-like homologs ([@bib44]). Moreover, catalytic efficiency (specific activity) may vary among active PLA~2~s. On the other hand, and in contrast to the highly variable expression of PLA~2~s, proteolytic activity did not vary widely among the studied venoms.

Regardless of their relative abundances, both PLA~2~s and metalloproteinases were detected by shotgun proteomics in all the studied venoms, together with serine proteinases, C-type lectins/lectin-like, and L-amino acid oxidases, as typical of viperids. Other protein families that appeared common to all venoms were nucleotidases and glutaminyl cyclotransferases. In contrast, some differences were observed among them regarding the detection of cysteine-rich secretory proteins, phosphodiesterases, nerve growth factors, phospholipases B, vascular endothelial growth factors, and hyaluronidases.

An inference of present results revealing the low expression of PLA~2~s in several bothropoid venoms from Perú is that they should display low toxicity for effects that depend mainly on this protein family. One of these known effects is myotoxicity ([@bib32]). To test this prediction, the venoms of *Bothrops barnetti* and *Bothrocophias andianus* were selected as representatives of the 'low-PLA~2~' phenotype and assayed *in vivo* for induction of muscle necrosis. Results demonstrated their negligible myotoxic effect. Whether this lack of myotoxicity confers any restriction on the trophic function of snake venoms that express it is still unknown, since information on diet and basic ecology is still very fragmented. Also, it is reasonable to expect that these differences in myotoxicity among bothropoid venoms, shown experimentally in mice, should translate to clinical envenomings. Envenomings by *Bothrops* (*sensu lato*) species are sometimes described in the Latin American medical literature as a single entity having shared general features. However, present results predict that important differences exist depending on the species, e.g., myonecrosis would not be expected in envenomings by species that express minimal amounts of venom PLA~2~s.

An indirect myotoxic action has been reported for some hemorrhagic metalloproteinases ([@bib66], [@bib33]), but their relative contribution to myonecrosis, in comparison to directly myotoxic PLA~2~s, has not been clearly established. Present results obtained in mice with *B. barnetti* and *B. andianus* venoms suggest that acute muscle damage would be largely driven by PLA~2~s, and are in agreement with studies that showed almost complete inhibition of myonecrosis when the venom of *B. asper* was neutralized by PLA~2~-specific polyclonal ([@bib46]) or monoclonal ([@bib47]) antibodies.

In addition to its interest from a medical perspective, from a biological standpoint, the study of inter-species variations might contribute to understanding the evolutionary events that shaped the venom proteomes of extant species. In this work, we attempted to visualize the positions and relationships of bothropoid species from Perú presenting low- or high-PLA~2~ venom phenotypes, based on the partial phylogeny generated by [@bib14]. Although the interspersed pattern of the two phenotypes precludes reaching a simple phylogenetic deduction, it is clear that bothropoid venoms rich in PLA~2~s are more common than those presenting scarce PLA~2~s, and that the latter tend to cluster partially in the "microphtalmus" clade (*Bothrocophias* species), and the "taeniata" clade. The basal phylogenetic position of *Bothrops barnetti* (having a "low-PLA~2~″ venom) for the "alternatus" clade is interesting and leads to note that all clades encompassing a combination of the two phenotypes present a "low-PLA~2~″ basal species in these phylogenetic trees. If this observation holds after examining a more significant number of species, it would be tempting to suggest that the increased expression of PLA~2~s could be an evolutionarily more derived phenotypic feature. However, since the available phylogenetic information is still incomplete and limited in species coverage, further studies will be required to understand the complex relationships between venom phenotypes and phylogeny. Currently enigmatic, understanding the selective forces that originated the highly variable expression of PLA~2~s in venoms of the *Bothrops* complex anticipates a challenging research task.

5. Concluding remarks {#sec5}
=====================

Venom is an intrinsically ecological trophic trait crucial for the foraging success of the organisms that produce it. The evolution of venom phenotypes does not appear to be phylogenetically constrained, but more likely shaped by ecological filtering that permits a small number of optimal solutions involving combinations of only a few major toxin families ([@bib5]). Of particular note is the occurrence of congeneric, even conspecific, divergent venom phenotypes, such as the 3FTx-rich/PLA~2~-predominant venoms described in venoms of the New World genus *Micrurus* (Elapinae) and sea snake (Hydrophiinae) lineages ([@bib73], [@bib51]); the PIII-SVMP (type-I)/β-neurotoxic heterodimeric PLA~2~ (type-II) venom compositional dichotomy found within *Crotalus* ([@bib52], [@bib56], [@bib11], [@bib79]) and *Bothriechis* ([@bib64]); and the divergent 3FTx/Kunitz-type dendrotoxins venom phenotypes among *Dendroaspis* ([@bib1]). The high/low PLA~2~ venom compositional divergence described here among venoms of Peruvian *Bothrops* species represents a new dichotomy. The finding of similar patterns of venom variability among evolutionarily distant snake lineages suggests that dichotomic venom phenotypes may constitute a more general trend than previously thought.

Venom dichotomy has different evolutionary origins in Nearctic, Central American, and South American rattlesnakes. Differential expression of type-I or type-II venom phenotypes in North American rattlesnakes appears to be due to recent lineage-independent losses of the genes coding for the subunits of the heterodimeric β-neurotoxin PLA~2~ ([@bib21], [@bib22]). In contrast, in Central American *C. simus* it is ontogenetic and post-transcriptionally modulated by miRNAs ([@bib23]). It represents a pedomorphic trait driven by the increased gain of neurotoxicity and lethal venom activity to mammals (rodents) in South American *Crotalus durissus* ([@bib9]). The 3FTx/PLA~2~ dichotomy among micrurine venoms may have been shaped by balancing selection ([@bib74]), an evolutionary scenario where local adaptation depends on the frequencies of the two toxin classes, with the hetero- (i.e. 3FTx + PLA~2~) phenotype having an advantage over the homo-phenotypes ([@bib43], [@bib87]). In contrast, the streamlined 3FTx venom of the aquatic coral snake *M. surinamensis* may have evolved under strong pressure to quickly immobilize aquatic prey ([@bib74], [@bib76]). The different evolutionary paths responsible for generating variation in venom composition underscore the importance of considering venom diversification in the proper historical scenario.

Diversification of venoms within *Bothrops* should be understood in the context of the evolution of this clade. The early colonization by the ancestor of all *Bothrops* had its roots in South America during the middle Miocene, 14.07 Mya (CI95% 16.37--11.75 Mya), and was followed much later by *Bothriechis schlegelii* (7--6.6 Mya), *Porthidium* (3.5 Mya), and *Crotalus durissus* (1 Mya) ([@bib88], [@bib62]; [@bib89], [@bib3]). *Bothrops* represents the most successful South American pitviper radiation, with extant lineages exhibiting extremely diverse morphological and ecological traits ([@bib55]). Except for southwestern South America, the extreme highlands of the Andes, and southernmost Patagonia, extant bothropoid pitvipers are widely distributed in tropical Latin America, from northeastern Mexico to Argentina, and the southern parts of the lower Caribbean islands, where they inhabit a broad spectrum of ecoregions, such as lowland evergreen forests, montane semideciduous forests, savannas, and open montane formations, from sea level to 3000 m of elevation (Campbell and Lamar, 1989; 2010[@bib12]; [@bib13]). Diversification of *Bothrops* should be understood in the context of the unique historical contingencies of the evolution of this clade, the absence of other pitvipers and placental carnivores as potential competitors or predators when their lineage radiated throughout South America ([@bib88]) and the orogenic processes that created vicariant events ([@bib34], [@bib70]). For example, in South America the uplift of the Central Andes mountain range (which began in the late Oligocene to early Miocene (23 Mya) with the formation of the highest peaks during the late Middle Miocene 11--12 Mya and continued until around 2--3 Mya, contemporaneous with deformation in the Santa Bárbara system to the east) (Folguera et al., 2011; [@bib34]), the uplift of the Guanacaste, Central, and Talamanca mountain ranges in Mesoamerica since the late Miocene or early Pliocene (8-5 Mya) to the Pliocene, and the closure of the Isthmus of Panama 3.2 Mya ([@bib30], [@bib61], [@bib7]), are some of the main vicariance events involved in the cladogenesis of the lancehead vipers as a consequence of the fragmentation of populations and allopatric speciation ([@bib39], [@bib71], [@bib34]). Recent phylogeographic analyses have shown that demographic processes and ecological differentiation in montane habitats would also be reliable drivers implicated in the divergence of different taxa along altitudinal gradients ([@bib70]).

An increasing number of studies support the idea that snake venom evolution is driven by diet-related selection pressures leading to local adaptations ([@bib18], [@bib4], [@bib78], [@bib19], [@bib36]). Adaptive venom variability represents a common phenomenon at all taxonomic levels among individuals of the same or different geographic locations, dietary habits, genders and across the life history stages of an individual ([@bib10], [@bib11]). Although the mechanisms of venom variation remain elusive, ecological release seemingly promotes increased phenotypic variance ([@bib84], [@bib8]). From a functional perspective, venom from a generalist viperid may have the capability to subdue different prey items, although with varying degrees of effectiveness. However, other dimensions, such as non-consumptive habitat use, or dietary decisions, define the trophic niche of the organism and have significant implications on the individual energy budget and the outcomes of interactions between sympatric taxa ([@bib35], [@bib86], [@bib6]).

Besides providing insights into the selective pressures that resulted in local adaptation and species-level divergence in venoms, understanding the evolutionary processes and the ecological constraints that moulded snake venoms to their present-day variation may also provide compelling insights into venom clinical toxicology. Thus, toxins that have the highest prey incapacitation activity to a mammalian model are often also the most medically important molecules in the context of a human envenoming. Identifying the molecular basis of venomous snake adaptation to their natural ecosystems may assist in the identification of those toxins that must be neutralized to reverse the effects of venom, thereby guiding the rational development of next-generation snakebite therapeutics.
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The following are the Supplementary data to this article:Multimedia component 1Multimedia component 1Supplemental Fig. S1RP-HPLC profiles of the venoms of *Bothrops ayerbei* from Colombia ([@bib59]) and *Bothrocophias campbelli* from Ecuador ([@bib69]), showing the large variability in the expression of phospholipase A~2~ proteins. These venoms are not included in the phylogenetic trees shown in Fig.7 and therefore their positions and relationships to other bothropoid species cannot be indicated. As indicated in the legend of Fig.2, the dotted light green shaded area indicates the known elution region for PLA~2~/PLA~2~-like proteins in viperid venoms in this standardized chromatographic gradient. These two species exemplify the evident dichotomy between venoms with "high-\" and "low-PLA~2~″ phenotypes among bothropoids. For reference to colors, the reader is referred to the web version of this article.Supplemental Fig. S1
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[^1]: Taxonomical nomenclature used in this work follows the proposal of [@bib14], which synonimizes *Rhinocerophis*, *Bothropoides*, and *Bothriopsis* with *Bothrops*, while maintaining *Bothrocophias* and assigning *Bothrops andianus* to that genus.

[^2]: n: number of individuals in the venom pool; nd: not determined.

[^3]: \* Abbreviations: **MP**: metalloproteinase; **SP**: serine proteinase; **PLA**~**2**~: phospholipase A~2~; **LAAO**: L-amino acid oxidase; **VEGF**: vascular endothelial growth factor; **NGF**: nerve growth factor; **CTL**: C-type lectin/lectin-like; **NUC**: nucleotidase; **PDE**: phosphodiesterase; **GCY**: Glutaminyl cyclotransferase; **PLB**: phospholipase B; **CRiSP**: cysteine-rich secretory protein; HYA: hyaluronidase. For a detailed summary of protein matches refer to [Supplemental Table S1](#appsec1){ref-type="sec"}.

[^4]: √: detected; (−) not detected.
